OLIGOMETASTATIC PROSTATE CANCER (OMPC)
Clinical trials for OLIGOMETASTATIC PROSTATE CANCER (OMPC) explained in plain language.
Never miss a new study
Get alerted when new OLIGOMETASTATIC PROSTATE CANCER (OMPC) trials appear
Sign up with your email to follow new studies for OLIGOMETASTATIC PROSTATE CANCER (OMPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental DNA vaccine aims to train immune system against prostate cancer
⭐️ VACCINE ⭐️ Recruiting nowThis early-phase trial tests whether an experimental DNA vaccine (pTVG-HP) combined with the immunotherapy drug nivolumab and targeted radiation can help the immune system attack prostate cancer that has returned in a few spots. The study involves 14 men whose cancer has come bac…
Matched conditions: OLIGOMETASTATIC PROSTATE CANCER (OMPC)
Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: ⭐️ VACCINE ⭐️
Last updated May 18, 2026 11:59 UTC
-
New radiation therapy aims to delay hormone treatment in prostate cancer
Disease control Recruiting nowThis study tests a radioactive drug (lutetium-177 vipivotide tetraxetan) in men with prostate cancer that has spread to a few spots after initial treatment. The goal is to see if it can delay the cancer from spreading further and postpone the need for hormone therapy. About 450 m…
Matched conditions: OLIGOMETASTATIC PROSTATE CANCER (OMPC)
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 22, 2026 13:50 UTC